Search

everythinglearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

A man developed skin cancer on his scalp after multiple artificial hair grafts.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

The letter argues that blaming synthetic hair implants for scalp cancer based on one report is biased and possibly coincidental.

A unique case of skin cancer showed unusual calcification, possibly linked to calcium-binding proteins.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Synthetic hair implants can cause scalp cancer years later.

Biopsy is crucial to accurately distinguish Erosive Pustular Dermatosis of the Scalp from Squamous Cell Carcinoma.

Biopsy is crucial for accurately diagnosing EPDS to avoid mistaking it for SCC.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Synthetic hair implants may pose health risks, including cancer, and require careful monitoring.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

A woman with a long-term skin condition developed a serious skin cancer that led to her death.

A 70-year-old man with skin cancer on both sides of his forehead was treated with surgery and cryotherapy, highlighting the need for early detection and prevention.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.